We are live on ! Find out more
NP

NS Partners Portfolio holdings

AUM $2.23B
1-Year Est. Return 20.03%
This Fund
S&P 500
This Quarter Est. Return
+12.13%
1 Year Est. Return
+20.03%
3 Year Est. Return
+81.73%
5 Year Est. Return
+107.4%
10 Year Est. Return
+450.74%
AUM
$1.9B
AUM Growth
+$172M
Cap. Flow
-$18.8M
Cap. Flow %
-0.99%
Top 10 Hldgs %
37%
Holding
73
New
Increased
36
Reduced
35
Closed
2

Top Sells

Rank Stock Value
1
HAE icon
Haemonetics
HAE
+$11.1M
2
JPM icon
JPMorgan Chase
JPM
+$10.3M
3
BAC icon
Bank of America
BAC
+$4.45M
4
MAR icon
Marriott International
MAR
+$3.84M
5
AAPL icon
Apple
AAPL
+$3.73M

Sector Composition

Rank Sector Weight
1 Technology 23.08%
2 Financials 21.01%
3 Healthcare 14.79%
4 Consumer Discretionary 13.22%
5 Communication Services 9.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEE icon
26
NextEra Energy
NEE
$185B
$25.4M 1.34%
347,002
-59
-0% -$4.43K
TMUS icon
27
T-Mobile US
TMUS
$208B
$25.3M 1.33%
174,964
-10,391
-6% -$1.43M
CRM icon
28
Salesforce
CRM
$140B
$24.4M 1.29%
99,996
+415
+0.4% +$95.6K
HON icon
29
Honeywell
HON
$71.3B
$24.1M 1.27%
116,514
-4,766
-4% -$1.01M
ZTS icon
30
Zoetis
ZTS
$32.1B
$23.8M 1.25%
127,697
-4,876
-4% -$847K
IDXX icon
31
Idexx Laboratories
IDXX
$44.8B
$23.7M 1.25%
37,457
-1,656
-4% -$914K
EFX icon
32
Equifax
EFX
$21.1B
$23.2M 1.22%
96,741
-4,101
-4% -$917K
BBD icon
33
Banco Bradesco
BBD
$37.4B
$23.1M 1.22%
4,958,099
+703,668
+17% +$3.06M
MKC icon
34
McCormick & Company Non-Voting
MKC
$13.9B
$21.9M 1.16%
248,447
+62,127
+33% +$5.54M
ISRG icon
35
Intuitive Surgical
ISRG
$122B
$21.5M 1.13%
70,050
+45
+0.1% +$12.6K
PEP icon
36
PepsiCo
PEP
$187B
$21.3M 1.12%
143,487
-7,916
-5% -$1.15M
YUM icon
37
Yum! Brands
YUM
$40.8B
$21.1M 1.11%
183,037
+1,764
+1% +$208K
VRSK icon
38
Verisk Analytics
VRSK
$26.3B
$20.8M 1.09%
118,849
+23,225
+24% +$4.12M
TSM icon
39
TSMC
TSM
$2.07T
$20.7M 1.09%
172,474
+4,716
+3% +$553K
VEEV icon
40
Veeva Systems
VEEV
$31.7B
$20.3M 1.07%
65,198
+278
+0.4% +$77.5K
BDX icon
41
Becton Dickinson
BDX
$43.6B
$20M 1.06%
84,440
-3,761
-4% -$902K
EW icon
42
Edwards Lifesciences
EW
$49.4B
$19.9M 1.05%
192,429
+722
+0.4% +$68.1K
VRSN icon
43
VeriSign
VRSN
$25.3B
$19.8M 1.04%
86,979
+2,088
+2% +$455K
SBUX icon
44
Starbucks
SBUX
$120B
$18.8M 0.99%
168,397
+720
+0.4% +$81.4K
ILMN icon
45
Illumina
ILMN
$28.2B
$18.7M 0.98%
40,562
+365
+0.9% +$147K
EQIX icon
46
Equinix
EQIX
$101B
$18.5M 0.97%
23,058
+3,863
+20% +$2.87M
DADA
47
DELISTED
Dada Nexus
DADA
$16.9M 0.89%
581,600
+114,700
+25% +$2.98M
TRU icon
48
TransUnion
TRU
$15.4B
$15.2M 0.8%
138,601
+467
+0.3% +$48.7K
BSX icon
49
Boston Scientific
BSX
$65.4B
$15M 0.79%
351,426
-21,709
-6% -$913K
MNST icon
50
Monster Beverage
MNST
$95.4B
$14.1M 0.74%
308,706
+2,144
+0.7% +$101K

Similar funds

NS Partners's Q2 2021 Portfolio in Review

As of Q2 2021, NS Partners held 73 positions worth $1.9B, up 10% from $1.73B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Trading was light in Q2 2021: portfolio turnover was 2.7%. NS Partners opened no new positions and exited 2, leaving the 73-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • NS Partners added most to McCormick & Company Non-Voting in Q2 2021, an estimated $5.54M increase.
  • NS Partners's biggest Q2 2021 reduction was JPMorgan Chase, cutting an estimated $10.3M.
  • NS Partners fully exited Haemonetics in Q2 2021, selling an estimated $11.1M.
  • NS Partners's ten largest holdings make up 37% of its $1.9B portfolio in Q2 2021.
  • NS Partners opened 0 new positions and closed 2 in Q2 2021.
  • NS Partners's portfolio value rose 10% quarter-over-quarter to $1.9B.

Based on NS Partners's 13F filing for Q2 2021, filed 2 Aug 2021.